- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-CD47
CD47 Monoclonal Antibody for FC, WB, ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain et plus (1)
Applications
WB, IF, FC, ELISA
Conjugaison
Non conjugué
CloneNo.
1E1D8
N° de cat : 66304-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules HeLa, cellules A549, cellules HT-1080, cellules HUVEC, cellules Jurkat, cellules K-562, cellules NCI-H1299, cellules SKOV-3, cellules TF-1, tissu placentaire humain |
Résultats positifs en cytométrie | cellules HUVEC |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:8000 |
Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
WB | See 8 publications below |
IF | See 1 publications below |
FC | See 1 publications below |
Informations sur le produit
66304-1-Ig cible CD47 dans les applications de WB, IF, FC, ELISA et montre une réactivité avec des échantillons Humain
Réactivité | Humain |
Réactivité citée | Humain, souris |
Hôte / Isotype | Mouse / IgG2b |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | CD47 Protéine recombinante Ag14132 |
Nom complet | CD47 molecule |
Masse moléculaire calculée | 323 aa, 35 kDa |
Poids moléculaire observé | 55 kDa |
Numéro d’acquisition GenBank | BC010016 |
Symbole du gène | CD47 |
Identification du gène (NCBI) | 961 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
CD47, also known as integrin-associated protein (IAP), is a member of the immunoglobulin superfamily containing a five-pass transmembrane attachment. CD47 is heavily glycosylated and widely expressed by hematopoietic and nonhematopoietic cells. CD47 interacts with several membrane integrins and also acts a receptor for thrombospondin (THBS1). It is involved in a range of cellular processes, including apoptosis, proliferation, adhesion, and migration. CD47 also functions as a ligand for signal regulatory protein-α (SIRPα). Upon binding CD47, SIRPα initiates a signaling cascade that results in the inhibition of phagocytosis.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for CD47 antibody 66304-1-Ig | Download protocol |
FC protocol for CD47 antibody 66304-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
J Control Release Erythrocyte-biomimetic nanosystems to improve antitumor effects of paclitaxel on epithelial cancers. | ||
J Nanobiotechnology Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC. | ||
RSC Adv Seedless preparation of Au nanorods by hydroquinone assistant and red blood cell membrane camouflage | ||
J Cell Commun Signal CD47 interactions with exportin-1 limit the targeting of m 7 G-modified RNAs to extracellular vesicles | ||
J Cancer Res Clin Oncol B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy | ||
J Clin Lab Anal MicroRNA-148a-3p inhibits cancer progression and is a novel screening biomarker for gastric cancer. |